Close
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq May 23, 2024 05:18PM

New York, NY, May 23, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) (“Fresh2” or the “Company”), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on May 23, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that due to its failure to timely file its Form 10-Q for the... (continue reading...)


NextEra Energy board declares quarterly dividend May 23, 2024 05:18PM

JUNO BEACH, Fla., May 23, 2024 /PRNewswire/ -- The board of directors of NextEra Energy, Inc. (NYSE: NEE) declared a regular quarterly common stock dividend of $0.515 per share. The dividend is payable on June 17, 2024, to shareholders of record on June 3, 2024.

NextEra Energy, Inc.NextEra Energy, Inc. (NYSE: NEE) is a leading clean energy company... (continue reading...)


Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers May 23, 2024 05:18PM
  • Oklo and Wyoming Hyperscale signed a non-binding letter of intent to collaborate on a 20-year Power Purchase Agreement.
  • Wyoming Hyperscale will aim to use Oklo’s Aurora powerhouses to power a state-of-the-art data center campus.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Oklo Inc. (NYSE: OKLO) (“Oklo”), a fast fission clean power technology and nuclear fuel recycling company, announced its collaboration with Wyoming Hyperscale to supply 100 megawatts of... (continue reading...)


American Aires Extends Global Expansion by Opening Latest International Fulfillment Center in the UK May 23, 2024 05:15PM
  • Aires ships direct-to-consumer orders to 60+ countries every month
  • Initial end-user shipments have already left the new UK fulfillment center
  • Sufficient time to fine tune fulfillment system & local marketing before holiday season

Toronto, Ontario--(Newsfile Corp. - May 23, 2024) - American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) ("Aires" or the "Company"), a pioneer in cutting-edge technology designed to protect against electromagnetic radiation and optimize human health,... (continue reading...)


Deveron Announces Dates for Q3 2024 Earnings Release May 23, 2024 05:15PM

Toronto, Ontario--(Newsfile Corp. - May 23, 2024) - Deveron Corp. (TSXV: FARM) ("Deveron" or the "Company"), a leading agriculture service and data company in North America, is pleased to announce that the Company's Q3 financial results will be released after market close on Tuesday May 28th, 2024. At that time, the financial results and related documents will be posted on SEDAR Plus and Deveron's financials web page at https://deveron.com/financials.

Deveron will hold... (continue reading...)


More Press Releases

View Older Stories

May 23, 2024 05:15PM Aurania Announces Closing of Tranche 2 of Private Placement
May 23, 2024 06:09PM Avenix Fzco Introduces New Expert Advisor Pivozon for Enhanced Forex Trading on EURUSD
May 23, 2024 05:15PM Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
May 23, 2024 05:15PM Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
May 23, 2024 05:15PM PARAMOUNT GLOBAL AND CHARTER COMMUNICATIONS ANNOUNCE NEW MULTI-YEAR AGREEMENT FOR DISTRIBUTION OF PARAMOUNT'S LINEAR NETWORKS, CBS OWNED-AND-OPERATED STATIONS AND DIRECT-TO-CONSUMER STREAMING SERVICES
May 23, 2024 05:15PM NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
May 23, 2024 05:15PM Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:13PM SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:12PM SILVERCORP REPORTS ADJUSTED NET INCOME OF $39.3 MILLION, $0.22 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $91.6 MILLION FOR FISCAL 2024
May 23, 2024 05:12PM Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
May 23, 2024 05:11PM Special Olympics Florida and Orlando Health Announce Five-Year Partnership
May 23, 2024 05:10PM Extraordinary 80+ Acre Paradise Island, Boca Grande, FL, Hits Market After 70-Years: A Once-in-a-Lifetime Opportunity for Discerning Buyers
May 23, 2024 05:10PM Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
May 23, 2024 05:10PM Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
May 23, 2024 05:10PM Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
May 23, 2024 05:09PM Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024 05:09PM KinderCare Learning Companies Applauds Bipartisan Effort to Support Working Families through Child Care Access
May 23, 2024 05:06PM G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024 05:05PM Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
May 23, 2024 05:05PM EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001, at the Upcoming 2024 ASCO Annual Meeting
May 23, 2024 05:05PM Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening
May 23, 2024 05:05PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (m
May 23, 2024 05:05PM NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:05PM Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
May 23, 2024 05:05PM Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer at the 2024 ASCO Ann
May 23, 2024 05:05PM ALIMENTATION COUCHE-TARD TO RELEASE RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2024 ON JUNE 25, 2024
May 23, 2024 05:05PM Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel
May 23, 2024 05:05PM BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:05PM IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal Melanoma
May 23, 2024 05:05PM Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the
May 23, 2024 05:05PM Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
May 23, 2024 05:05PM TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
May 23, 2024 05:05PM I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024
May 23, 2024 05:05PM Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
May 23, 2024 05:05PM TelevisaUnivision Announces Pricing of $1.0 Billion Debt
May 23, 2024 05:05PM Elcora Announces Share Consolidation
May 23, 2024 05:05PM Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinica
May 23, 2024 05:04PM Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
May 23, 2024 05:04PM BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares Distribution
May 23, 2024 05:03PM Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
May 23, 2024 05:02PM White House National Cyber Director Coker Discusses Cybersecurity Implementation Plan 2.0 at Conference Hosted by McCrary Institute for Cyber & Critical Infrastructure Security
May 23, 2024 05:02PM KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
May 23, 2024 05:02PM Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
May 23, 2024 05:00PM Sierra Madre Announces Francisco Correa as General Manager of La Guitarra Mine and Mill Complex, Grants Incentive Options
May 23, 2024 05:00PM Cleantek Industries Inc. Announces First Quarter 2024 Results
May 23, 2024 05:00PM Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
May 23, 2024 05:01PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meet
May 23, 2024 05:01PM Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First
May 23, 2024 05:01PM NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
May 23, 2024 05:01PM Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST
View Older Stories